Neurophysiological study of critical illness polyneuropathy and myopathy in mechanically ventilated children; additional aspects in paediatric critical illness comorbidities

European Journal of Neurology

Volumn 25, Issue 7, 2018, Pages 991-998

  Thabet Mahmoud, A ^a   Tawfik, M A M ^a   Abd el naby, S A ^a   Abo El Fotoh, W M M ^a   Saleh, N Y ^a   Abd El Hady, N M S ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

critical illness; electromyography; mechanical ventilation; myopathy; nerve conduction; polyneuropathy

Indexed keywords

ALBUMIN; CALCIUM; GLUCOSE;

ACIDOSIS; ADOLESCENT; ALBUMIN BLOOD LEVEL; AROUSAL; ARTICLE; ARTIFICIAL VENTILATION; CALCIUM BLOOD LEVEL; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRITICAL ILLNESS; ELECTROMYOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL MORTALITY; HUMAN; HYPERTRANSAMINASEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYOPATHY; NERVE CONDUCTION; PEDIATRIC INTENSIVE CARE UNIT; PLATELET COUNT; POLYNEUROPATHY; PRIORITY JOURNAL; PROTHROMBIN TIME; VENTILATED PATIENT; VENTILATOR WEANING; COMPLICATION; INTENSIVE CARE UNIT; MUSCLE DISEASE; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MUSCLE STRENGTH; MUSCULAR DISEASES; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; POLYNEUROPATHIES; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 85048631884     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.13649     Document Type: Article

References (45)

1. Shepherd S, Batra A, Lerner DP. Review of critical illness myopathy and neuropathy. Neurohospitalist 2017; 7: 41–48.
2. Kukreti V, Shamim M, Khilnani P. Intensive care unit-acquired weakness in children: critical illness polyneuropathy and myopathy. Indian J Crit Care Med 2014; 18: 95–101.
3. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failures. Chest 1991; 99: 176–184.
4. Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000; 56: 211–214.
5. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33: 711–715.
6. Hermans G, Van den Berghe G. Clinical review: intensive care unit-acquired weakness. Crit Care 2015; 19: 274.
7. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10: 931–941.
8. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: critical illness polyneuropathy and myopathy. Crit Care 2008; 12: 238.
9. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failures. Brain 1987; 110: 819–841.
10. Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995; 21: 737–743.
11. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicenter CRIMYNE study. J Neurol Neurosurg Psychiatry 2008; 79: 838–841.
12. Koch S, Wollersheim T, Bierbrauer J, et al. Long-term recovery in critical illness myopathy is complete, contrary to polyneuropathy. Muscle Nerve 2014; 50: 431–436.
13. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–1367.
14. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175: 480–489.
15. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomized controlled trial. Lancet 2009; 373: 1874–1882.
16. Routsi C, Gerovasili V, Vasileiadis I, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care 2010; 14: R74.
17. Kreit JW, Rogers RM. Approach to the patient with respiratory failure. In: Shoemaker A, Grenvik H, eds. Textbook of Critical Care. Philadelphia, PA: WB Saunders, 1995: 680–687.
18. Hall JB, Schmidt GA, Wood LD. Acute hypoxemic respiratory failure. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. Philadelphia, PA: Saunders, 2000: 2413–2442.
19. National Heart, Lung, and Blood Institute (NHLBI) Workshop on respiratory muscle fatigue: report of the respiratory muscle fatigue workshop group. Am Rev Resp Dis 1990; 142: 474–480.
20. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality score. Crit Care Med 1988; 16: 1110–1116.
21. Slater A, Shann F, Pearson G. PIM 2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 2003; 29: 278–285.
22. Kleyweg RP, van der Meche FG, Meulstee J. Treatment of Guillain−Barré syndrome with high-dose g-globulin. Neurology 1988; 38: 1639–1641.
23. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009; 37(Suppl.): S299–S308.
24. Nguyen The L, Nguyen Huu C. Critical illness polyneuropathy, and myopathy in a rural area in Vietnam. J Neurol Sci 2015; 357: 276–281.
25. Ali NA, O'Brien JM, Hoffmann SP, et al. Acquired weakness, hand grip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178: 261–268.
26. Vondracek P, Bednarik J. Clinical and electrophysiological findings and long-term outcomes in pediatric patients with critical illness polyneuromyopathy. Eur J Paediatr Neurol 2006; 10: 176–181.
27. Williams S, Horrocks IA, Ouvrier RA, Gillis J, Ryan MM. Critical illness polyneuropathy and myopathy in pediatric intensive care: a review. Pediatr Crit Care Med 2007; 8: 18–22.
28. De Jonghe B, Bastuji-Garin S, Durand MC, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007; 35: 2007–2015.
29. Mirzakhani H, Williams JN, Mello J, et al. Muscle weakness predicts pharyngeal dysfunction and symptomatic aspiration in long-term ventilated patients. Anesthesiology 2013; 119: 389–397.
30. Sharshar T, Bastuji-Garin S, Stevens RD, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening is associated with increased intensive care unit and hospital mortality. Crit Care Med 2009; 37: 3047–3053.
31. Xue F, An G, Liao X, Zou Q, Luo L. The pharmacokinetics of vecuronium in male and female patients. Anesth Analg 1998; 86: 1322–1327.
32. Miller AE, MacDougall JD, Tarnopolsky MA, Sale DG. Gender differences in strength and muscle fiber characteristics. Eur J Appl Physiol Occup Physiol 1993; 66: 254–262.
33. Berk L. Infants and Children: Prenatal through Middle Childhood, 6th edn. Boston, MA: Allyn & Bacon, 2008.
34. Hermans G, Vanhorebeek I, Derde S, Van den Berghe G. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med 2009; 37: 391–397.
35. Koch S, Bierbrauer J, Haas K, et al. Critical illness polyneuropathy in ICU patients is related to reduced motor nerve excitability caused by reduced sodium permeability. Intensive Care Med Exp 2016; 4: 10.
36. Z'Graggen WJ, Lin CS, Howard RS, Beale RJ, Bostock H. Nerve excitability changes in critical illness polyneuropathy. Brain 2006; 129: 2461–2470.
37. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology 2010; 2010: 135–143.
38. Nesseler N, Launey Y, Aninat C, Morel F, Mallédant Y, Seguin P. Clinical review: the liver in sepsis. Crit Care 2012; 16: 235.
39. Kellum JK. Metabolic acidosis in patients with sepsis: epiphenomenon or part of the pathophysiology? Crit Care Resusc 2004; 6: 197–203.
40. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996; 40: 645–654.
41. Srinivasan V. Stress hyperglycemia in pediatric critical illness. The intensive care unit adds to the stress!. J Diabetes Sci Technol 2012; 6: 37–47.
42. Mazeraud A, Polito A, Annane D. Experimental and clinical evidence for glucose control in intensive care: is infused glucose the key point for study interpretation? Crit Care 2014; 18: 232.
43. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007; 33: 1876–1891.
44. Aubier M, Viires N, Piquet J, et al. Effects of hypocalcemia on diaphragmatic strength generation. J Appl Physiol 1985; 58: 2054.
45. Mitch WE. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr 2006; 16: 208–211.